Patrick

2024

April

<div class="textg" style="text-align: justify; font-weight: lighter; line-height: 1.3em; font-size: 15px; border-radius: 3px; color: #80909a; padding: 10px; background-color: #F4F6F9; margin-bottom: 15px;">
 Neither the author, Tim Fries, nor this website, The Tokenist, provide financial advice. Please consult our&nbsp;<a href="https://tokenist.com/terms-of-service/" style="text-decoration:underline;color:#3c7b7b" target="_blank" rel="noopener noreferrer nofollow" class="deco-link">website policy</a>&nbsp;prior to making financial decisions.
</div>
<p class="has-drop-cap">In a volatile trading day, three stocks stood out for their significant price movements following earnings reports and corporate updates. Axon Enterprise (<a href="https://tokenist.com/investing/how-to-buy-stocks/" rel="noopener noreferrer nofollow" class="deco-link">NASDAQ: AXON</a>) saw a substantial surge due to strong AI service demand, while Lyft (<a href="https://tokenist.com/investing/how-to-invest-in-stocks/" class="deco-link" rel="noopener noreferrer nofollow">NASDAQ: LYFT</a>) and Novo Nordisk (<a href="https://tokenist.com/investing/how-to-buy-shares-online/" class="deco-link" rel="noopener noreferrer nofollow">NYSE: NVO</a>) experienced sharp declines amid disappointing financial results and lowered forecasts.</p>
<h3 id="axon-enterprise-sees-an-ai-driven-surge">Axon Enterprise Sees an AI-Driven Surge</h3>
<p>Axon Enterprise shares skyrocketed 19.41% to $352.25 by midday, driven by strong demand for its new <a aria-label="artificial intelligence service (opens in a new tab)" href="https://www.prnewswire.com/news-releases/axon-reimagines-report-writing-with-draft-one-a-first-of-its-kind-ai-powered-force-multiplier-for-public-safety-302124489.html" target="_blank" rel="noopener noreferrer nofollow" class="deco-link">artificial intelligence service</a>.<br><br>The company, known for supplying Tasers and body cameras to law enforcement, reported second-quarter earnings that beat estimates. Axon’s revenue jumped 34.6% to $504.1 million, with <a href="https://tokenist.com/investing/how-to-value-a-stock/" rel="noopener noreferrer nofollow" class="deco-link">earnings per share</a> rising 9% to $1.20.<br><br>The highlight was Draft One, an AI service launched in April that automates police report writing. CEO Patrick Smith noted that customer response to Draft One was “better than anything I’ve seen,” with the product generating over $100 million in yet-to-be-recorded revenue faster than any other Axon software product. The company raised its full-year revenue outlook to $2-$2.05 billion, up from $1.94-$1.99 billion.</p>
<div class="cta-referral"><img src="https://tokenist.com/wp-content/themes/thetokenist/assets/img/del/cta-referral-1.png" alt="" class="cta-referral__img" loading="lazy" decoding="async">
 <div class="cta-referral__text">
  <p>Join our&nbsp;<a href="https://t.me/thetokenist" target="_blank" rel="noopener noreferrer nofollow" class="deco-link">Telegram group&nbsp;and never miss a breaking story.</a></p>
 </div>
</div>
<h3 id="lyft-s-ride-sharing-slump">Lyft’s Ride-Sharing Slump</h3>
<p>Lyft shares tumbled 11.75% to $9.68 following <a href="https://investor.lyft.com/overview/default.aspx" target="_blank" aria-label="disappointing second-quarter results and a weak outlook (opens in a new tab)" rel="noopener noreferrer nofollow" class="deco-link">disappointing second-quarter results and a weak outlook</a>. The ride-sharing company reported gross bookings of $4.02 billion, falling short of analyst expectations. Its forecast for third-quarter bookings of $4-$4.1 billion also missed the $4.14 billion analyst projection.<br><br>Despite posting its first quarterly GAAP profit of $5 million and seeing adjusted earnings more than double to $102.9 million, investors were unimpressed. Lyft did report a 16% increase in rides to restaurants, bars, and entertainment venues, but the overall results suggested softening consumer spending in the gig economy sector.<br><br>The company revised its full-year expectation to convert over 90% of adjusted EBITDA to free cash flow, up from its previous guidance of over 70%.</p>
<h3 id="novo-nordisk-s-weight-loss-drug-woes">Novo Nordisk’s Weight-Loss Drug Woes</h3>
<p>Novo Nordisk (NVO) shares fell 7.85% to $119.91 after the Danish pharmaceutical giant <a href="https://www.reuters.com/business/healthcare-pharmaceuticals/obesity-drugmaker-novo-nordisk-misses-q2-profit-forecast-2024-08-07/" target="_blank" aria-label="cut its annual profit expectations due to weaker-than-expected sales (opens in a new tab)" rel="noopener noreferrer nofollow" class="deco-link">cut its annual profit expectations due to weaker-than-expected sales</a> of its weight-loss drug Wegovy.<br><br>Second-quarter Wegovy sales grew 55% to 11.66 billion Danish kroner, but this fell short of the 13.54 billion kroner analysts had forecast. Sales of Ozempic, another key product, also narrowly missed expectations. Novo Nordisk reduced its 2024 operating profit forecast to 20-28% growth from the previous 22-30% range, citing “expected, continued periodic supply constraints.”<br><br>The company faces increasing competition from rival Eli Lilly’s (NYSE: LLY) drugs Zepbound and Mounjaro in the fast-growing market for weight-loss treatments. Despite the setback, Novo Nordisk slightly raised its sales growth estimate to 22-28% from 19-27%.</p> <iframe src="https://tokenist.substack.com/embed" width="100%" height="320" style="border:1px solid #EEE; background:white;" frameborder="0" scrolling="no"></iframe>
<p><em>Disclaimer: The author does not hold or have a position in any securities discussed in the article.</em></p>
<h3 id="br"><br></h3>
<p>The post <a rel="noopener noreferrer nofollow" href="https://tokenist.com/stocks-to-watch-today-axon-lyft-and-novo-nordisk/">Stocks to Watch Today: AXON, LYFT, and Novo Nordisk</a> appeared first on <a rel="noopener noreferrer nofollow" href="https://tokenist.com">Tokenist</a>.</p>

Stocks to Watch Today: AXON, LYFT, and Novo Nordisk

Table of Contents

Tokenist

Other articles published on Aug 7, 2024

Binance Inflows Soar to $1.2 Billion Amid Crypto Market Recovery

Uniswap V4 may bring new types of scams

Buy The Blood: 3 Cryptocurrencies With Strong Buy Signals Set For Big Price Rallies

Shiba Inu Whales Secure Their 1000x Profits From New ICO Rival

Mystery Shiba Inu Whale Empties Major US Exchange of 220 Billion SHIB

Compound Finance Faces Scrutiny After Controversial Proposal 289 Passes

Join our free newsletter for daily crypto updates!